NORTHWEST BIOTHERAPEUTICS INC — Net Income by Fiscal Year
29 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/70ce430e-5b88-47f0-aaa7-056dcf84041b/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-60.2M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-043806 |
| FY 2024 | $-83.8M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000598 |
| FY 2023 | $-62.6M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-000133 |
| FY 2022 | $-105.0M | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000185 |
| FY 2021 | $179.1M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000244 |
| FY 2020 | $-529.8M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-044832 |
| FY 2019 | $-20.8M | 2019-01-01 – 2019-12-31 | evidence 0001104659-21-044832 |
| FY 2018 | $-35.8M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-017803 |
| FY 2017 | $-73.1M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-020971 |
| FY 2016 | $-80.2M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-020754 |
| FY 2015 | $-114.7M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-088301 |
| FY 2014 | $-135.6M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-016579 |
| FY 2013 | $-386.1M | 1996-03-18 – 2014-03-31 | evidence 0001144204-14-031414 |
| FY 2012 | $-288.7M | 1996-03-18 – 2013-03-31 | evidence 0001144204-13-029641 |
| FY 2011 | $-217.1M | 1996-03-18 – 2012-03-31 | evidence 0001144204-12-030833 |
| FY 2010 | $-27.4M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-021574 |
| FY 2009 | $-27.0M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-021574 |
| FY 2008 | $-22.3M | 2008-01-01 – 2008-12-31 | evidence 0001144204-12-021574 |
| FY 2007 | $-21.2M | 2007-01-01 – 2007-12-31 | evidence 0001144204-12-021574 |
| FY 2006 | $-1.4M | 2006-01-01 – 2006-12-31 | evidence 0001144204-12-021574 |
| FY 2005 | $-9.9M | 2005-01-01 – 2005-12-31 | evidence 0001144204-12-021574 |
| FY 2004 | $-8.5M | 2004-01-01 – 2004-12-31 | evidence 0001144204-12-021574 |
| FY 2003 | $-5.8M | 2003-01-01 – 2003-12-31 | evidence 0001144204-12-021574 |
| FY 2002 | $-12.8M | 2002-01-01 – 2002-12-31 | evidence 0001144204-12-021574 |
| FY 2001 | $-10.9M | 2001-01-01 – 2001-12-31 | evidence 0001144204-12-021574 |
| FY 2000 | $-12.8M | 2000-01-01 – 2000-12-31 | evidence 0001144204-12-021574 |
| FY 1999 | $-5.6M | 1999-01-01 – 1999-12-31 | evidence 0001144204-12-021574 |
| FY 1998 | $-4.7M | 1998-01-01 – 1998-12-31 | evidence 0001144204-12-021574 |
| FY 1997 | $-2.6M | 1997-01-01 – 1997-12-31 | evidence 0001144204-12-021574 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NORTHWEST BIOTHERAPEUTICS INC — all facts · Revenue · Operating Income